Who has invested in Maple?

Acton Capital, SE Health, Shoppers Drug Mart Inc. are named among the investors backing Maple.

Maple Funding: $91M Raised, Series B (2020)

Maple funding overview

Maple is based in Toronto, Canada. Maple has raised $91M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2020. The round record for Maple runs through 2020; nothing later has been disclosed. Investors on record include Acton Capital, SE Health, Shoppers Drug Mart Inc.. 3 distinct backers are named across the disclosed rounds.

Maple at a glance

Total raised: $91M
Latest round: Series B
Latest round date: January 2020
Headquarters: Toronto, Canada
Notable investors: Acton Capital, SE Health, Shoppers Drug Mart Inc.

Frequently asked about Maple funding

How much has Maple raised?: Maple has raised $91M in total disclosed funding across the rounds on record.
Who has invested in Maple?: Acton Capital, SE Health, Shoppers Drug Mart Inc. are named among the investors backing Maple.
What was the latest Maple funding round?: The most recent disclosed round is a Series B, announced in January 2020.
Where is Maple based?: Maple is based in Toronto, Canada.
When did Maple last raise?: The last disclosed Maple round closed in January 2020 at Series B.

Maple totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Toronto below to benchmark round size and investor mix.

Maple Funding: $91M Raised, Series B (2020)

Maple funding overview

Maple at a glance

Frequently asked about Maple funding

Companies related to Maple (27)

Browse related funding lists (6)